EVOPRIDE + 1/500MG TAB Lucid 500mg Tablet Conditions such as chronic obstructive

Conditions such as chronic obstructive pulmonary disease (COPD) and asthma

Suitable for short-term and long-term management of inflammatory disorders

and watery eyes caused by allergic rhinitis and urticaria

It is not indicated for diabetes type 1

Take one tablet 30 minutes before bedtime for best results

EVOPRIDE + 1/500MG TAB Lucid 500mg Tablet Conditions such as chronic obstructiveEVOPRIDE + combines Glimepiride 1mg and Metformin HCl 500mg in a single tablet, designed to help manage type 2 diabetes effectively. Glimepiride stimulates insulin secretion from the pancreas, while Metformin improves insulin sensitivity and reduces glucose production in the liver. This dual action formulation works synergistically to control blood sugar levels throughout the day. Suitable for patients requiring combination therapy when monotherapy is